Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

2013, A Year Of Turmoil For Eli Lilly
Seeking Alpha
Saturday, February 16, 2013 - 12:24pm
tags:
Eli Lilly
Takeda Worried About Actos’s Cancer Link, Filing Shows
BusinessWeek
Saturday, February 16, 2013 - 12:22pm
tags:
type 2 diabetes, Takeda, diabetes, cancer, Actos
Medicare Drug Costs to Be Reduced for Seniors, U.S. Says
Bloomberg
Saturday, February 16, 2013 - 12:21pm
tags:
Medicare
Is This Pipeline Biologic a Future Blockbuster?
Motley Fool
Saturday, February 16, 2013 - 12:20pm
tags:
CNTO 136, JNJ, sirukumab, GSK, rheumatoid arthritis
Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin
PharmaLive
Saturday, February 16, 2013 - 12:16pm
tags:
Oramed Pharmaceuticals, oral insulin, type 1 diabetes, type 2 diabetes, ORMD-0801, ORMD-0901
3 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, February 16, 2013 - 12:09pm
tags:
Lannett, Perrigo, Watson Pharmaceuticals
Teva risking $2bn damages from early launch of generic Protonix?
PharmaTimes
Saturday, February 16, 2013 - 12:07pm
tags:
Teva, Protonix, generics
1 Event Eli Lilly Investors Must Watch (video)
Motley Fool
Saturday, February 16, 2013 - 12:01pm
tags:
Eli Lilly
Pharmacyclics jumps on drug approval plans
Yahoo/AP
Saturday, February 16, 2013 - 11:59am
tags:
Pharmacyclics, ibrutinib, mantle cell lymphoma
GlaxoSmithKline and Pfizer's HIV Joint Venture Gets Priority Review for Dolutegravir
Motley Fool
Saturday, February 16, 2013 - 11:58am
tags:
GSK, Pfizer, HIV, Dolutegravir
Sanofi's Orphan Drug Eliglustat Tartrate Successful in 2 Late-Stage Trials
Motley Fool
Saturday, February 16, 2013 - 11:55am
tags:
Sanofi, orphan drugs, eliglustat tartrate, Gaucher disease
Merck Finally Settles Over Vytorin
Seeking Alpha
Saturday, February 16, 2013 - 11:53am
tags:
Vytorin, Merck, lawsuits
Better Dividend: Merck or Pfizer?
Motley Fool
Saturday, February 16, 2013 - 11:53am
tags:
Merck, Pfizer
J&J Tested Vaginal Mesh and Warned of Risks, Lawyer Says
Bloomberg
Saturday, February 16, 2013 - 11:43am
tags:
JNJ, vaginal mesh
AbbVie Suspends Five Clinical Trials of Leukemia Therapy
Bloomberg
Saturday, February 16, 2013 - 11:42am
tags:
ABT-199, Abbott Laboratories
AstraZeneca Inks Deal
Yahoo/Zacks
Saturday, February 16, 2013 - 11:41am
tags:
AstraZeneca
This Mid-Cap Pharmaceutical is a Prime Takeover Target
Motley Fool
Saturday, February 16, 2013 - 11:36am
tags:
Biomarin
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, February 16, 2013 - 11:35am
tags:
JNJ, Pharmacyclics, Herbalife
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, February 16, 2013 - 11:34am
tags:
Amicus Therapeutics, eHealth, Hospira
Gilead Issues a Voluntary Recall of One Lot of Vistide® (Cidofovir Injection) Due to Presence of Particulate Matter
Yahoo/BusinessWire
Saturday, February 16, 2013 - 11:33am
tags:
Gilead Sciences, Vistide, cytomegalovirus retinitis, HIV

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.